Next Article in Journal
The Developmental Mechanism of the Root System of Cultivated Terrestrial Watercress
Next Article in Special Issue
Assessment of Chemical Composition and In Vitro Antioxidant, Antidiabetic, Anticholinesterase and Microbial Virulence-Quenching Effects of Salad Burnet (Sanguisorba minor L.) Harvested from Algeria
Previous Article in Journal
Total Content of Saponins, Phenols and Flavonoids and Antioxidant and Antimicrobial Activity of In Vitro Culture of Allochrusa gypsophiloides (Regel) Schischk Compared to Wild Plants
Previous Article in Special Issue
Abelmoschus eculentus Seed Extract Exhibits In Vitro and In Vivo Anti-Alzheimer’s Potential Supported by Metabolomic and Computational Investigation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Plants
Volume 12
Issue 20
10.3390/plants12203522
plants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phytochemical Characterization and In Vitro Evaluation of the Anti-Sickle Cell Activity of Aqueous and Ethanolic Extracts of Two Medicinal Plants from Niger: Flueggea virosa (Roxb. ex Willd.) Royle and Kigelia africana (Lam.) Benth

by
Harouna Dieté Souleymane
1,
Alfa Keita Djibo
1,
Sabo Haoua Seyni
2,
Ousseini Zakaria
2,
Andreea Veronica Botezatu
3,
Rodica Mihaela Dinica
3,*,
Adamou Ibrahim Maman Laouali
4 and
N’goran David Vincent Kouakou
5
1
Laboratory of Natural Substances and Organic Synthesis, Department of Chemistry, Faculty of Sciences and Techniques, Abdou Moumouni University of Niamey, Niamey BP 10662, Niger
2
Laboratory for Valorization of Agro-Resources, Biochemistry Section, Department of chemistry, Faculty of Sciences and Techniques, Abdou Moumouni University of Niamey, Niamey BP 10662, Niger
3
Department of Chemistry, Physics and Environment, Faculty of Sciences and Environment, “Dunarea de Jos” University of Galati, 800201 Galati, Romania
4
Laboratory of Biostatistics, Department of Biology, Faculty of Sciences and Techniques, Abdou Moumouni University of Niamey, Niamey BP 10662, Niger
5
Department of Training and Research in Agriculture and Animal Resources, National Polytechnic Institute of Félix Houphouët-Boigny, Yamoussoukro BP 1313, Côte d’Ivoire
*
Author to whom correspondence should be addressed.
Plants 2023, 12(20), 3522; https://doi.org/10.3390/plants12203522
Submission received: 2 September 2023 / Revised: 30 September 2023 / Accepted: 3 October 2023 / Published: 10 October 2023
(This article belongs to the Special Issue Biological Activities of Plant Extracts II)
Browse Figures
Versions Notes

Abstract

:
Sickle cell anaemia is a hereditary blood disorder that attacks the red blood cells and deforms them, giving them a sickle shape. Sickle cell anaemia is a serious health problem in the West African country of Niger. Moreover, the cost associated with medical care is very high. The main objective of this study is to contribute to the valorisation of Flueggea virosa (Roxb. ex Willd.) Royle (aerial part), Kigelia africana (lam), and Benth (leaves) from Niger were used to treat sickle cell disease using aqueous and ethanolic extracts of phytochemical compounds. To achieve this objective, the evaluation of anti-sickle cell activity was carried out in vitro using the Emmel technique through the normalisation rate. The analyses showed that the aqueous and ethanolic extracts contained various classes of bioactive substances known for their valuable biological activities. The chemical composition rich in bioactive compounds led to very good results in biological assays. Thus, from a dose of 0.05 mg/mL, the ethanolic extracts of the two plants normalised up to 75% of the sickle cells. As the rate of normalisation was shown to be dose-dependent, at a dose of 10 mg/mL, the ethanolic extracts showed the best rates of sickle cell normalisation, with 95% for F. virosa and 93% for K. africana. Phytochemical screening was used to correlate the secondary metabolite and anti-sickle cell activities of the extracts from the two plants. These results may justify the use of these two species in traditional medicine for the treatment of sickle cell disease in Niger. The inclusion of these plants in phytomedicines could provide significant relief to people suffering from sickle cell disease.

1. Introduction

Sickle cell anaemia is a hereditary disease caused by a qualitative structural anomaly in haemoglobin. This effect is due to a point mutation in the sixth adenine codon and its replacement with thymine in the β-chain coding for globin. This DNA mutation is characterised by the substitution of an amino acid (glutamic acid) with valine at position 6 of the β chain. This anomaly is located on chromosome 11 [1,2]. According to the World Health Organization (WHO), it is the most common genetic disease in the world, affecting approximately 50 million people [3]. Every year, 300,000 children are born with a major haemoglobin abnormality, and there are more than 200,000 cases in Africa, with a prevalence of 13%. Haemoglobinopathies represent the most frequent category of clinically significant inherited diseases, with an enormous public health burden, and sickle cell disease is the most common haemoglobinopathy in sub-Saharan Africa [4]. In sub-Saharan Africa, where the majority of affected individuals are found, the disease is often fatal to children under the age of 5 [5]. In Niger, as in most Sahelian countries, sickle cell anaemia is one of the most impactful diseases. During the cold season (December to February), there are more sickle cell crises, with high infant morbidity and mortality in the most vulnerable groups, that is, mother–child pairs. Every year, 1000 new cases are recorded, with 0.5–1% of deaths occurring in 5% of the affected population. This condition affects 22% to 25% of the population of Niger [6]. Several therapeutic options, such as bone marrow transplants, repeated blood transfusions, and hydroxyurea, have been developed to combat sickle cell disease. These treatments are inaccessible to African populations because they are very expensive. They can also pose a risk of transmitting diseases such as hepatitis and HIV/AIDS [7,8,9]. In Niger, the population has acquired several years of experience with the traditional treatment of illnesses using plants, as reported by [10] in an ethnobotanical survey of traditional health practitioners in the Tillabery and Niamey regions.
Therefore, it is important to carry out scientific studies to prove and highlight the biological properties of these plants in terms of their anti-sickle cell activity due to their chemical composition. As the chemical composition has been described in other studies, this study was undertaken to evaluate the biological properties and propose the inclusion of these two medicinal plants in the Nigerien Pharmacopoeia.

2. Results

2.1. Extract Yield

The yields in (%) mass/mass of the aqueous and ethanolic crude extracts of both plants are given in Table 1. It can be seen that more substances were extracted in F. virosa using both solvents than in K. africana (Table 1).

2.2. Phytochemical Screening

Phytochemical screening of the crude aqueous and ethanolic extracts of F. virosa and K. africana revealed the richness of these plant species in chemical compounds. All nine chemical groups (alkaloids, sterols and triterpenes, saponosides, flavonoids, free quinones, tannins, anthocyanins, reducing sugars, and aromatic amino acids) were detected in F. virosa and K. africana (Table 2).

2.3. In Vitro Evaluation of the Antifalcemic Activity

Figure 1, Figure 2 and Figure 3 present micrographs of sickle cells and erythrocytes from the control (SS blood not treated with the plant extract) and SS samples treated with aqueous and ethanolic extracts of F. virosa and K. africana at a concentration of 2.5 mg/mL. A concentration of 2.5 mg/mL was used to illustrate the shape of the red blood cells after treatment of the blood samples with the extracts (Figure 2 and Figure 3). Figure 1 shows that there were more sickle cells than normal erythrocytes in SS blood untreated with the crude extracts of the two plants; in contrast, in Figure 2 and Figure 3, there were more normal erythrocytes than sickle cells in SS samples treated with the aqueous and ethanolic extracts of F. virosa (Figure 2) and K. africana (Figure 3) at a concentration of 2.5 mg/mL.
The high rates of normalisation of red blood cells in the SS blood samples treated with the extracts showed that the two plants contained substances that could return sickle cells to a normal form, under in vitro hypoxic conditions, compared with the negative control, for which the number of sickle cells was high. Generally, a plant is considered an anti-sickle cell when it can normalise 50% of the sickle cells. From the first dose (0.05 mg/mL), all ethanolic extracts of the two plants normalised the number of sickle cells by up to 75% (Figure 4). It should be noted that the greatest anti-sickle cell activity was observed more in the ethanolic extracts than in the aqueous extracts. The highest rates of sickle cell normalisation were obtained at a dose of 10 mg/mL, with a rate of 95% for the ethanolic extract of F. virosa, followed by that of the ethanolic extract of K. africana (93%) and then the normalisation rates for the aqueous extracts of F. virosa (90%) and K. africana (85%) (Table 3).
Although these two plants belong to different families, their normalization rates were statistically identical: F. virosa (62.25 ± 34.41%) and K. africana (81.75 ± 7.36%) were not significant, the variance was equal to 0.139 above the probability threshold (p > 0.05), and these two plants are in the same group (a) in terms of modalities.
In addition, depending on the solvent used for extraction, it was observed that the normalisation rate of ethanolic extracts (85 ± 8.1%) was statistically different from that of aqueous extracts (59 ± 31.68 %), and the variance equal to 0.041 was lower than the probability threshold (p < 0.05). These two extracts were obtained using different groups of modalities.
The difference observed between the rate of sickle cell normalisation in aqueous and ethanolic extracts of the two plants could be explained by the difference in the polarity of the solvents. These results indicate that the chemical groups responsible for the anti-sickle cell activity could be less polar compounds and more soluble in ethanol than in water.

3. Discussion

The average yield of the ethanolic extracts was higher than that of the aqueous extracts, indicating that extracted ethanol had more phytochemical compounds than water.

3.1. Phytochemical Screening

Phytochemical screening of Flueggea virosa by Benin [11] detected the presence of gallic and catechic tannins, flavonoids, and anthocyanins in Flueggea virosa. In this study, in addition to these compounds, alkaloids, quinone derivatives, triterpenes and sterols, saponosides, reducing compounds, and aromatic amino acids were identified in F. virosa from Niger (Table 4). This wealth of phytochemicals justifies the use of the leaves, twigs, and bark in Niger’s traditional medicine to treat illnesses, such as sickle cell anaemia, allergic and infectious dermatitis, stomach ache, and heart pain [10]. The plant is also used to treat fever, malaria, genital dysfunction, pain, diabetes, epilepsy, venereal disorders, diarrhoea, pneumonia, cough, AIDS, and as a contraceptive [12]. Various indolizidine alkaloids, including isomers and securin derivatives, have been isolated from the organs of Flueggea virosa, namely virosecurinine (0.5% in the leaves), viroallosecurinine, norsecurinine, and dihydronorsecurinine (virosine). Other alkaloids, such as hordenine and N-methyltetrahydro-β-carboline, have also been isolated. Other compounds isolated from F. virosa leaves include isocoumarin, bergenin, gallic acid, ellagic acid, and flavonoids (quercetin and rutin). The DPPH free radical scavenging assay of F. virosa showed that corilagin, rutin, and gallic acid displayed strong antioxidant activities, with DPPH radical scavenging capacities of 82.74%, 75.31% and 91.83% at a concentration of 200 μg/mL, respectively [13] (Table 4).
F. virosa twigs contain around 8% tannins [14,15]. Two dimeric indolizidine alkaloids, flueggines A and B, were isolated from the twigs and leaves of Flueggea virosa. Aqueous extracts of F. virosa root have demonstrated anti-inflammatory and antipyretic activities, with a significant effect observed at a dose of 400 mg/kg. Acute toxicity was assessed in rats, where the extract was administered orally at a dose of 10,000 mg/kg, and no deaths were recorded [16].
In the second plant, Kigelia africana, nine families of chemical compounds were identified during phytochemical screening (alkaloids, triterpenes and sterols, flavonoids, quinone derivatives, saponosides, tannins, anthocyanins, reducing compounds, and aromatic amino acids). The presence of alkaloids, sterols, triterpenes, and saponosides has already been reported in K. africana from Niger by [17]; however, these authors did not identify any tannins, flavonoids, quinones, or cyanogenic glycosides in the plant, compounds that were found in the samples investigated in the current study (Table 5). This could be due to differences in harvesting area or harvesting time. The richness of its compounds justifies its use in traditional Nigerien medicine, where the leaves, bark, and fruit are used in treating sickle cell disease, diabetes, wounds, dysentery, and gastritis [10]. Various chemical constituents, such as naphthaquinones, iridoids, fatty acids, norviburtinal, sterols, lignans, terpenoids, caffeic acid, flavonoids, and kigelinone, have been reported in K. africana [18,19]. In another study, the total phenolic content in the examined extract was found to be 3.53g of GA/100 g of the methanolic extract of Kigelia africana from India [20] (Table 5).

3.2. In Vitro Evaluation of the Antifalcemic Activity

The results in Figure 4 show that the percentages of normalisation of sickle cell (thus, the antifalcemic activity) were dose-dependent with the dose of the plant extract. Thus, the higher the concentration of the extract, the higher the normalization rate. Other authors have reported this fact in the literature [22,23]. Thus, [24] found anti-sickle cell activity in polar (aqueous, methanolic) and medium polar (ethyl acetate) crude extracts of Ocimum canun (Lamiaceae), with apolar (n-hexane and dichloromethane) extracts of the plant being without activity. According to these authors, anthocyanins and polar compounds in these extracts are responsible for the anti-sickle cell activities of the plant, with a maximum normalisation rate of 88.5% for sickle cells. Similarly, [25] found high anti-sickle cell activities with aqueous extracts of Jatropha curcas and Dichrostachys cinerea, with sickle cell inhibition rates of 97% and 91%, respectively, and an inhibition rate of only 32% for Khaya senegalensis. It was also found that the methanolic and ethyl acetate extracts were responsible for the antifalcemic activities of Combretum glutinosom leaves, with sickle cell conversion rates of 81% and 89%, respectively [26]. A high sickle cell normalisation rate (71%) was reported by [27] for the aqueous extract of a recipe (mixture of plants) used to combat sickle cell disease, in which Cissus populnea is the main plant. However, these authors found a higher normalisation rate (62%) for the chloroformic extract of Cissus populnea than for the aqueous extract (more polar) of the same plant (53%).
The antifalcemic activities of the polar extracts of medicinal plants have been attributed to certain molecules, such as polar, vitamin C and phenylalanine [28], vanillic acid [29], p-hydroxybenzoic acid [27,28,29,30], ortho-3,4-divalloylquinic acid, ortho-3,5 divalloylquinic acid, ortho-4,5-divalloylquinic acid [31], phenylalanine [30,32], and polar chemical compounds such as alkaloids [1], anthocyanins [1], flavonoids [26], quinones [28], tannins [33], organic acids [31], and aromatic amino acids [30,32]. The results of the phytochemical screening showed that the ethanolic and aqueous extracts of F. virosa and K. africana contained some of these families of chemical compounds, namely alkaloids, anthocyanins, flavonoids, free quinones, tannins, and aromatic amino acids.
It is, therefore, likely that, through the synergistic effect or alone, these phytochemical groups may be at the basis of the in vitro anti-sickle cell activity of these two plants and could justify their use as anti-sickle cell plants in traditional Nigerien medicine. Thus, aqueous and ethanolic extracts of F. virosa and K. africana contain compounds that can prevent complications related to sickle cell disease, including polyphenols, flavonoids, and anthocyanins.
These compounds are known to act both on haemoglobin S polymerisation under hypoxic conditions and on the erythrocyte membrane [1]. They inhibit haemoglobin S polymerisation by engaging in a competitive reaction with this protein. In addition, their antioxidant properties enable them to prevent the peroxidation of membrane lipids, thus preventing erythrocyte lysis. Anthocyanins are effective scavengers of free radicals and are, therefore, powerful inhibitors of lipid peroxidation.
In addition, the phytochemicals in the ethanolic and aqueous extracts of F. virosa and K. africana, owing to their antioxidant potential, are thought to target vasocclusion by modulating inflammatory responses to stabilise sickle cell membranes in order to prevent haemolysis-mediated endothelial dysfunction [34] (Figure 5).
A phytomedicine based on these compounds could protect the membranes of sickle cell patients by supplementing the enzymatic defence systems of deficient erythrocyte. They could also stabilise haemoglobin S by increasing its affinity for oxygen and promoting better circulation of water in erythrocytes, as reported by its author [35,36,37,38].

4. Materials and Methods

4.1. Chemicals and Reagents

All the organic reagents and solvents were purchased from Fisher Scientific (Strasbourg, France).

4.2. Biological Material

The biological material consisted of SS homozygous sickle cell haemoglobin blood collected from a patient with sickle cell disease at the National Reference Center for sickle cell disease (CNRD) at the national hospital in Niamey (Niger). This is the only centre specialized in the screening, treatment, and management of sickle cell disease. This blood sample was used to evaluate the antifalcemic activity of the crude extracts of the two plants. It was collected in EDTA tubes from a patient not recently transfused.

4.3. Plant Material and Preparation of Extracts

4.3.1. Plant Material and the Selection Criteria for the Two Plant Species

To list the plants used in the fight against sickle cell disease in Niger, we used the results of the ethnobotanical survey carried out by [10] among traditional health practitioners in the Niamey and Tillabéri regions. This document reported the local names of plants presumed to be anti-sickle cells and the method of preparation of the recipe for the traditional medicine used to treat sickle cell disease. This enabled us to draw up a list of 23 plants. After a review of the literature, two plants whose anti-sickle cell activity had not been studied were selected. These were the aerial parts of Flueggea virosa (Roxb. ex Willd.) Royle and the leaves of Kigelia africana (lam) Benth., two medicinal plants used in the Nigerien pharmacopoeia for the treatment of sickle cell disease and other pathologies. Plant material collected from the rural commune of Liboré (in the Tillabéri region of Niger) was shade-dried, crushed, and sieved. It was identified at the Botanical Laboratory of the Biology Department of Abdou Moumouni University, Niamey. The plant powder was preserved in brown glass jars and stored in wooden cupboards.

4.3.2. Preparation of the Crude Extracts of Both Plants

Plant powder (10 g) was weighed in a clean bottle using a PIONNER precision balance (to 0.001 g) (manufactured from Nänikon, Switzerland), transferred to a 250 mL Erlenmeyer flask, and 100 mL of solvent (distilled water or ethanol) was added to the powder. The mixture was macerated for 48 h at laboratory temperature (approximately 25 °C). Filtration was carried out after 48 h of maceration. The obtained macerates were filtered through cotton, and the solvents were removed using a rotary evaporator for the ethanolic extracts and a sand bath for the aqueous crude extracts to obtain the dry crude extracts. The yield (mass/mass percentage) of the crude extract was determined as follows: r = mass of dry crude extract × 100/mass of the sample powder. Before experimentation, each dry extract was stored in a brown vial and placed in a wooden cabinet to protect the photolabile compounds.

4.4. Phytochemical Screening

Different chemical groups (alkaloids, sterols and triterpenes, saponosides, flavonoids, free quinones, tannins, anthocyanins, reducing sugars, and aromatic amino acids) were characterized using techniques described in reference [39,40].

4.5. Evaluation of In Vitro Antifalcemic Activity

The Emmel technique, adapted by [41], is generally used to demonstrate the effects of plant extracts on the morphology of sickle cells.
The falciformation test for the control sample consisted of placing a drop of SS blood in a drop of physiological water (NaCl 0.9%) and sodium metabisulfite (Na2S2O5) between the slides. The slides were then glued to coverslips using candle wax. The mixture was depleted of oxygen, which caused red blood cells to falciform.
For the test sample, the falciformation test consists of placing a drop of SS blood in a drop of physiological water (NaCl 0.9%) and sodium metabisulfite (Na2S2O5) with a drop of plant extract at a given concentration (at varying concentrations: 10 mg/mL, 5 mg/mL, 2.5 mg/mL, and 0.05 mg/mL) between the slides. The slides were then glued to coverslips using candle wax. After 24 h of incubation, normal and sickle cell erythrocytes were counted via observation of the control and test slides under a light microscope with an objective (×40). The determination of sickle cells from 100 red blood cells was performed using a handheld counter [42]. Finally, the digitization of the images of sickle cell red blood cells, before and after treatment with the crude extracts of the plants, was performed using a Sony cyber-shot 10.1-megapixel digital camera manufactured from Tokyo (Japan).

4.6. Statistical Analyses

Data analysis was performed using the Excel 2013 spreadsheet. Analysis of variance (ANOVA) was used to test the difference between the two plants and between the two extracts in terms of normalisation rate. This analysis was performed using R software version 3.6.0 (R Development Core Team, 2019), and a p-value of less than 0.05 was found to be significantly different.

5. Conclusions

This study aimed to confirm the presumed anti-sickle cell activity of two plants from the Niger Pharmacopoeia and to determine the families of chemical compounds in their crude aqueous and ethanolic extracts. Our results confirmed the in vitro anti-sickle cell activity of F. virosa and K. africana, two plants used in traditional medicine in the Niamey and Tillabery regions, Niger, to treat SS anaemia. Anti-sickle cell activity: Starting at a dose of 0.05 mg/mL, the ethanolic extracts of the two plants normalised up to 75% of sickle cells. The greatest effects were observed in ethanolic extracts rather than aqueous extracts, with a normalisation rate for ethanolic extracts of 95% for F. virosa and 93% for K. africana, respectively, and for aqueous extracts of 90% for F. virosa and 85% for K. africana, at a concentration of 10 mg/mL. This activity could be mainly due to polyphenols, amino acids, and other organic acids, alone or with a possible synergistic effect of other families of compounds contained in the plants. Given the results, these two plants could make a significant contribution to the treatment of sickle cell disease in Niger through their use as phytomedicines.
In this study, bio-guided fractionation was performed to isolate the active ingredients and assess the toxicity of these two plants to develop a potential phytomedicine.

Author Contributions

Conceptualization: H.D.S. and A.K.D.; methodology: H.D.S. and A.K.D.; software, A.I.M.L.; validation: S.H.S., A.K.D. and R.M.D.; formal analysis: H.D.S. and O.Z.; investigation: H.D.S.; resources: S.H.S., A.K.D. and R.M.D.; data curation: H.D.S.; writing—original draft preparation: H.D.S., S.H.S., A.K.D. and A.V.B.; writing—review and editing: S.H.S., A.K.D., A.V.B., N.D.V.K. and R.M.D.; supervision: S.H.S.; project administration: S.H.S., A.K.D. and R.M.D. All authors have read and agreed to the published version of the manuscript.

Funding

The APC was funded by Dunarea de Jos University of Galati.

Data Availability Statement

Not applicable.

Acknowledgments

We thank the REXDAN project, SMIS code 127065, project co-financed by the European Regional Development Fund through the Competitiveness Operational Program 2014–2020, contract no. 309/10.07.2020.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mpiana, P.T.; Mudogo, V.; Tshibangu, D.S.T.; Shetonde, O.M.; Ngbolua, K.N.; Mbala, M.B. In vitro antisickling activity of anthocyanins extract of a Congolese plant: Alchornea cordifilia. M. Arg. J. Med. Sci. 2007, 7, 1182–1186. [Google Scholar] [CrossRef]
  2. Ibrahim, H.; Sani, F.S.; Danladi, B.H.; Ahmadu, A.A. Phytochemical and antisickling studies of the leaves of Hymenocardia acidaTul (Euphorbiaceae). Pak. J. Biol. Sci. 2007, 10, 788–791. [Google Scholar] [CrossRef] [PubMed]
  3. Organisation Mondiale de la Santé. Statistiques Sanitaires Mondiales; WHO: Geneva, Switzerland, 2014; p. 177. Available online: https://apps.who.int/iris/handle/10665/131954 (accessed on 9 November 2019).
  4. Mabiala, J.R.; Nzingoula, S.; Senga, P. Les crises vaso-occlusives drépanocytaires chez l’enfant et l’adolescent à Brazzaville, Congo. Étude rétrospective de 587 cas. Bull. Soc. Pathol. Exot. 2005, 98, 365–370. [Google Scholar]
  5. Labie, D.; Elion, J. La drépanocytose: Problème de l’Afrique. Med. Trop. 2010, 70, 449–453. [Google Scholar]
  6. Guide de la Prise en Charge de la Drépanocytose au Niger du Ministère de la Santé Publique. Available online: www.anpe.ne/article/drepanocytose (accessed on 9 November 2019).
  7. Wajcman, H.; Lantz, B.; Girot, R. Les Maladies du Globule Rouge. In Médecine-Science Flammarion; INSERM Edition; Flammarion: Paris, France, 1992; 1361p. [Google Scholar]
  8. Mehanna, A.S. Sickle Cell anaemia and antisickling agents: Then and now. Curr. Med. Chem. 2002, 8, 79–88. [Google Scholar] [CrossRef]
  9. Eliot, R.; Davies, M.; Harmse, D.J. Dermatomyositis-like eruption with long-term hydroxyurea. Dermatolog. Treat. 2006, 17, 56–60. [Google Scholar] [CrossRef]
  10. Jazy, M.A.; Karim, S.; Morou, B.; Sanogo, R.; Mahamane, S. Enquête Ethnobotanique Auprès des Tradipraticiens de Santé des Régions de Niamey et Tillaberi au Niger: Données 2012–2017. Eur. Sci. J. 2017, 13, 276–304. [Google Scholar] [CrossRef]
  11. Fagbohoun, L.; Gbaguidi, A.F.; Ayedoun, A.A.; Mathe, C.; Moudachirou, M.; Vieillescazes, C. Etudes ethnobotanique et phytochimique des plantes tinctoriales sources de colorants naturels et matériaux résineux traditionnels du Bénin dans le domaine artisanal (Ifangni/Bénin). Ethnopharmacologia 2014, 52, 56–66. [Google Scholar]
  12. Adnan, J.A.; Muhammad, Y.; Mohammad, S.A.; Volodymyr, S.; Xing-Cong, L.; Ilias, M.; Kamal, E.H. Chemical and biological study of Flueggea virosa native to Saudi Arabia. Chem. Nat. Compd. 2015, 51, 187–188. [Google Scholar]
  13. Peng, Y.L.; Zeng, N.; Yao, Q.Y.; Peng, C.Y.; Sheng, W.B.; Li, B.; Wang, W. A Review of the Medicinal Uses, Phytochemistry and Pharmacology of Genus Flueggea. Curr. Chin. Sci. 2023, 3, 213–241. [Google Scholar] [CrossRef]
  14. Li-She, G.; Jian-Min, Y. Alkaloids from the root of Flueggea virosa. Nat. Prod. Commun. 2006, 1, 819–823. [Google Scholar]
  15. Wang, G.; Liang, J.; Wang, Y.; Li, Q.; Ye, W. Chemical Constituents from Flueggea virosa. Chin. J. Nat. Med. 2008, 6, 251–253. [Google Scholar] [CrossRef]
  16. Ezeonwumelu, J.O.C.; Omar, A.N.; Ajayi, A.M.; Okoruwa, A.G.; Tanayen, J.K.; Kiplagat, D.M.; Okpanachi, O.A.; Abba, S.; Ezekiel, I.; Onchweri, A.N.; et al. Phytochemical screening, acute toxicity, anti-inflammatory and antipyretic studies of aqueous extract of the root of Flueggea virosa (Roxb. ex Willd.) in rats. Int. J. Pharm. Biomed. 2012, 3, 128–135. [Google Scholar]
  17. Ikhiri, K.; Boureima, D.; Dan Dicko, D.K. Chemical Screening of Medicinal Plants used in the Traditional Pharmacopoeia of Niger. Pharm. Biol. 1992, 30, 251–262. [Google Scholar] [CrossRef]
  18. Akunyili, D.; Houghton, P.; Raman, A. Antimicrobial activities of the stem bark of Kigelia pinnata. J. Ethnopharmacol. 1991, 35, 173–177. [Google Scholar] [CrossRef] [PubMed]
  19. Olatunji, A.G.; Atolani, O. Comprehensive scientific demystification of Kigelia africana: A review. African J. Pure Appl. Chem. 2009, 3, 158–164. [Google Scholar]
  20. Priya, B.; Menkudal, A.; Gahlot, M.; Joshi, P.; Agarwal, M. Pharmacognostical study, phytochemical analysis and phenolic content of Kigelia africana leaves. Int. J. Pharm. Pharm. Sci. 2013, 5, 163–166. [Google Scholar]
  21. Costa, R.; Albergamo, A.; Pellizzeri, V. Phytochemical screening by LC-MS and LC-PDA of ethanolic extracts from the fruits of Kigelia africana (Lam.) Benth. Nat. Prod. Res. 2016, 31, 1397–1402. [Google Scholar] [CrossRef]
  22. Sall, C.; Ndoye, S.F.; Dioum, M.D.; Seck, I.; Gueye, R.S.; Faye, B.; Thiam, C.T.; Seck, M.; Gueye, P.M.; Fall, D.; et al. Phytochemical study and in vitro activity evaluation of antisickling of two plants using in senegalese pharmacopeia. J. Chem. Pharm. Res. 2017, 9, 51–55. [Google Scholar]
  23. Mpiana, P.T.; Mudogo, V.; Ngbolua, K.N.; Tshibangu, D.S.T.; Atibu, E.K.; Mangwal, K.P.; Mbala, M.B.; Makelele, L.K.; Bokota, M.T. Antisickling activity and thermostability of anthocyanins extract from a congolese plant, Hymenocardia acida Tul. (Hymenocardiaceae). Int. J. Pharmacol. 2009, 5, 65–70. [Google Scholar] [CrossRef]
  24. Tshilanda, D.D.; Onyamboko, D.V.; Mwanangombo, D.T.; Tsalu, P.V.; Misengabu, N.K.; Tshibangu, D.S.T.; Ngbolua, K.N.; Mpiana, P.T. In vitro Antisickling Activity of Anthocyanins from Ocimum canun (Lamiacea). J. Adv. Med. Life Sci. 2015, 3, 6. [Google Scholar]
  25. Sawadogo, S.; Sanou, S.D.; Dabire, P.; Belemtougri, G.R.; Sawadogo, L.X.; Leiris, J.; Tanguy, S.; Boucher, S. Activité antifalcémiante d’extraits de trois plantes médicinales du Bukina Faso: Jatropha curcas, Khaya senegalensis et Dichrostachys cinerea. Int. J. Biol. Chem. Sci. 2017, 11, 2016–2027. [Google Scholar] [CrossRef]
  26. Sall, C.; Ndoye, S.F.; Dioum, M.D.; Seck, I.; Gueye, R.S.; Faye, B.; Thiam, C.T.; Seck, M.; Gueye, P.M.; Fall, D.; et al. Phytochemical Screening, Evaluation of Antioxidant and Anti-sickling Activities of Two Polar Extracts of Combretum glutinosum Leaves. Perr. ex DC. Br. J. Appl. Sci. Technol. 2017, 19, 1–11. [Google Scholar] [CrossRef]
  27. Moody, J.O.; Ojo, O.O.; Omotade, O.O.; Adeyemo, A.A.; Olumese, P.E.; Ogundipe, O.O. Antisickling potential of a Nigerian herbal formula (Ajawaron HF) and the major plant component (Cissus populnea L. CPK). Phytotherapy 2003, 10, 1173–1176. [Google Scholar] [CrossRef] [PubMed]
  28. Nwaoguikpe, R.N.; Braide, W. Some Fruit Juices as Environmental Sickling agents. World J. Med. Sci. 2011, 6, 61–67. [Google Scholar]
  29. Osoba, O.A.; Adesanya, S.A.; Durosimi, M.A. Effect of Lanthoxylum xantholoides and some substituted benzoic acids on glucose-6-phosphate and 6-phosphogluconate deshydrogenase in Hb ss red blood cells. Am. J. Hematol. 2001, 67, 1516. [Google Scholar]
  30. Akojie, F.O.; Fung, L.W. Antisickling activity of hydrobenzoic acids in Cajanus cajan. Planta Med. 1992, 58, 317–320. [Google Scholar] [CrossRef]
  31. Ouattara, B.; Angenot, L.; Guissou, P.; Fondu, P.; Dubois, J.; Frederich, M.; Jansen, O.; Van Heugen, J.C.; Wauters, J.N.; Tits, M. LC/MS/NMR analysis of divanilloylquinic acids form bark of Fagara zanthoxyloides Lam. Phytochemicals 2004, 65, 1145–1151. [Google Scholar] [CrossRef]
  32. Ekeke, G.I.; Shode, F.O. Phenylalanine is the predominant antisickling agent in Cajanus cajan seed extract. Plant Med. 1990, 56, 41–43. [Google Scholar] [CrossRef]
  33. Adejumo, O.E.; Kolapo, A.L.; Roleola, O.P.; Kasim, L.S. In vitro antisickling activities and phytochemical evaluation of Plumbago zeylanica and Uvaria. Afr. J. Biotechnol. 2010, 9, 9032–9036. [Google Scholar]
  34. Alabi, O.J.; Adegboyega, F.N.; Olawoyin, D.S.; Babatunde, O.A. Functional foods: Promising therapeutics for Nigerian Children with sickle cell diseases. Heliyon 2022, 8, e09630. [Google Scholar] [CrossRef] [PubMed]
  35. Mpiana, P.T.; Mudogo, V.; Tshibangu, D.S.T.; Shetonde, O.M.; Ngbolua, K.N.; Mbala, M.B. Antisicklingactivity of some Congolese plants. In Drug Discovery from African Flora, Proceedings of the 12th Symposium of the Natural Product Research Network for Eastern and Central Africa, Kampala, Uganda, 22–26 July 2007; University of Nairobi: Nairobi, Kenya, 2007; pp. 22–26. [Google Scholar]
  36. Mpiana, P.T.; Tshibangu, D.S.T.; Shetonde, O.M.; Ngobolwa, K.N. In vitro antidrepanocytary activity (anti-sickle cell anemia) of some Congolese plant. Phytomedecine 2007, 14, 192–194. [Google Scholar] [CrossRef] [PubMed]
  37. Mpiana, P.T.; Mudogo, V.; Tshibangu, D.S.T.; Ngbolua, K.N.; Tshilanda, D.D.; Atibu, E.K. Antisickling activity of anthocyanins of Jatropha curcas L. RPMP. Chem. Med. Val. 2008, 25, 101–108. [Google Scholar]
  38. Mpiana, P.T.; Makelele, L.K.; Oleko, R.W.; Bokota, M.T.; Tshibangu, D.S.T.; Ngbolua, K.N.; Mbala, M.B.; Atibu, E.K.; Nsimba, S.M. Antisickling activity of medicinal plants used in the management of Sickle cell Disease in Tshopo district, D.R. Congo. Aust. J. Med. Herb. 2010, 22, 132–137. [Google Scholar]
  39. Békro, Y.A.; Békro, J.A.M.; Boua, B.B.; Tra, B.F.H.; Ehilé, E.E. Etude ethnobotanique et screening phytochimique de Caesalpinia benthamiana (Baill.) Herend. et Zarucchi (Caesalpiniaceae). Rev. Sci. Nat. 2007, 4, 217–225. [Google Scholar] [CrossRef]
  40. N’Guessan, K.; Kadja, B.; Zirihi, G.; Traoré, D.; Aké-Assi, L. Screening phytochimique de quelques plantes médicinales ivoiriennes utilisées en pays Krobou (Agboville, Côte-d’Ivoire). Sci. Nat. 2009, 6, 1–15. [Google Scholar] [CrossRef]
  41. Caquet, R. 250 Examens de Laboratoire, 11th ed.; Masson: Paris, France, 2004; p. 480. [Google Scholar]
  42. Yuma, P.M.; Mpiana, P.T.; Bokota, M.T.; Wakenge, I.B.; Muanishay, C.L.; Gbolo, B.Z.; Di Mathina, G.M.; Tshibangu, D.S.T.; et Ngbolua, K.N. Étude de l’activitéantifalcemiante et de la thermo- et photo-dégradation des anthocyanes de Centella asiatica, Thomandersiahensii et Maesopsis eminii. Int. J. Biol. Chem. Sci. 2013, 7, 1892–1901. [Google Scholar] [CrossRef]
Plants 12 03522 g001
Figure 1. Morphology of sickle cells in untreated SS blood (400× magnification).
Figure 1. Morphology of sickle cells in untreated SS blood (400× magnification).
Plants 12 03522 g001
Plants 12 03522 g002
Figure 2. (a) Micrograph of SS blood sickle cells treated with ethanolic extract of F. virosa at a concentration of 2.5 mg/mL (400×), (b) Micrograph of SS blood sickle cells treated with ethanolic extract of F. virosa at a concentration of 2.5 mg/mL.
Figure 2. (a) Micrograph of SS blood sickle cells treated with ethanolic extract of F. virosa at a concentration of 2.5 mg/mL (400×), (b) Micrograph of SS blood sickle cells treated with ethanolic extract of F. virosa at a concentration of 2.5 mg/mL.
Plants 12 03522 g002
Plants 12 03522 g003
Figure 3. (a) Micrograph of sickle cells from SS blood treated with aqueous extract of K. africana at a concentration of 2.5 mg/mL (400×), (b) Micrograph of sickle cells from SS blood treated with ethanolic extract of K. africana at a concentration of 2.5 mg/mL (400×).
Figure 3. (a) Micrograph of sickle cells from SS blood treated with aqueous extract of K. africana at a concentration of 2.5 mg/mL (400×), (b) Micrograph of sickle cells from SS blood treated with ethanolic extract of K. africana at a concentration of 2.5 mg/mL (400×).
Plants 12 03522 g003
Plants 12 03522 g004
Figure 4. Normalisation rate of sickle cells in the presence of the extracts according to the concentrations of the crude extracts of F. virosa and K. africana. Legend: Et-F.V. ethanolic extract of F. virosa; ET-K.A. ethanolic extract of K. Africana; Aq-F.V. aqueous extract of F. virosa; Aq-K.A. aqueous extract of K. africana.
Figure 4. Normalisation rate of sickle cells in the presence of the extracts according to the concentrations of the crude extracts of F. virosa and K. africana. Legend: Et-F.V. ethanolic extract of F. virosa; ET-K.A. ethanolic extract of K. Africana; Aq-F.V. aqueous extract of F. virosa; Aq-K.A. aqueous extract of K. africana.
Plants 12 03522 g004
Plants 12 03522 g005
Figure 5. Proposed anti-sickle cell mechanisms of F. virosa and K. africana extracts.
Figure 5. Proposed anti-sickle cell mechanisms of F. virosa and K. africana extracts.
Plants 12 03522 g005
Table 1. Yields of ethanolic and aqueous extracts of the organs of the two presumed anti-sickle cell plants.
Table 1. Yields of ethanolic and aqueous extracts of the organs of the two presumed anti-sickle cell plants.
PlantsFamilyOrgan UsedExtraction ModePlants Yield (%)
Flueggea virosa (Rxb. ex Wild.) VoigtEuphorbiaceaeAerial partAqueous12.4
Ethanolic19.8
Kigelia Africana (Lam.) Benth.BignoniaceaeLeavesAqueous11.3
Ethanolic5.5
Table 2. Phytochemical screening of two anti-sickle cell plants.
Table 2. Phytochemical screening of two anti-sickle cell plants.
PlantsOrganExtractAlc.Ster.Fla.Sap.Qui.Tan.An.Suc.AA.
Flueggea virosa (Rxb. ex Wild.) Voigt DW
Aerial partH2O+++++++++
EtOH+++−+++++
Kigelia Africana (Lam.) Benth.LeavesH2O−++++++++
EtOH+++++++++
Alc. Alkaloides; D. Dragendorff; W. Wagner; Ster. Sterols and triterpenes; Fla. Flavonoids; Sap. Saponosides; Qui. Free quinones; Tan. Tannins; An. Anthocyanins; Suc. Reducing sugars; AA. Aromatic Amino Acid; +: presence of substances; −: absence of substances; H2O. aqueous; EtOH. ethanolic.
Table 3. Rate of normalisation of ethanolic and aqueous extracts from the organs of the two presumed anti-sickle cell plants.
Table 3. Rate of normalisation of ethanolic and aqueous extracts from the organs of the two presumed anti-sickle cell plants.
PlantsType of ExtractRate of Normalization
Flueggea virosa (Rxb. ex Wild.) VoigtAqueous90%
Ethanolic95%
Kigelia africana (Lam.) Benth.Aqueous85%
Ethanolic93%
Table 4. Phytochemical compounds isolated from Flueggea virosa [13].
Table 4. Phytochemical compounds isolated from Flueggea virosa [13].
Compound NameCompound Class
(−)-securinineAlkaloid
VirosecurinineAlkaloid
(+)-norsecurinineAlkaloid
(−)-virosine BAlkaloid
(+)-virosine BAlkaloid
Flueggine AAlkaloid
Flueggine BAlkaloid
Flueggether AAlkaloid
Flueggether BAlkaloid
Flueggether CAlkaloid
RutinFlavonoid
IsoquercitrinFlavonoid
KaempferolFlavonoid
QuercetinFlavonoid
GallocatechinFlavonoid
Epi-gallocatechinFlavonoid
(+)-catechinFlavonoid
p-hydroxybenzoic acidPhenolic acid
Vanillic acidPhenolic acid
BergeninPolyphenol
GlucogallinPolyphenol
CorilaginPolyphenol
Table 5. Phytochemical compounds isolated from Kigelia africana [21].
Table 5. Phytochemical compounds isolated from Kigelia africana [21].
Compoundmg/kg
Caffeic acid glucoside38.51 ± 1.20
p-Coumaroyl glucose21.40 ± 0.92
Caffeic acid83.01 ± 1.56
p-Coumaric acid27.82 ± 0.81
Ferulic acid19.40 ± 0.67
Verbascoside146.86 ± 3.14
Verminoside473.88 ± 5.37
Specioside44.39 ± 0.70
Minecoside12.98 ± 0.43
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Souleymane, H.D.; Djibo, A.K.; Seyni, S.H.; Zakaria, O.; Botezatu, A.V.; Dinica, R.M.; Ibrahim Maman Laouali, A.; Kouakou, N.D.V. Phytochemical Characterization and In Vitro Evaluation of the Anti-Sickle Cell Activity of Aqueous and Ethanolic Extracts of Two Medicinal Plants from Niger: Flueggea virosa (Roxb. ex Willd.) Royle and Kigelia africana (Lam.) Benth. Plants 2023, 12, 3522. https://doi.org/10.3390/plants12203522

AMA Style

Souleymane HD, Djibo AK, Seyni SH, Zakaria O, Botezatu AV, Dinica RM, Ibrahim Maman Laouali A, Kouakou NDV. Phytochemical Characterization and In Vitro Evaluation of the Anti-Sickle Cell Activity of Aqueous and Ethanolic Extracts of Two Medicinal Plants from Niger: Flueggea virosa (Roxb. ex Willd.) Royle and Kigelia africana (Lam.) Benth. Plants. 2023; 12(20):3522. https://doi.org/10.3390/plants12203522

Chicago/Turabian Style

Souleymane, Harouna Dieté, Alfa Keita Djibo, Sabo Haoua Seyni, Ousseini Zakaria, Andreea Veronica Botezatu, Rodica Mihaela Dinica, Adamou Ibrahim Maman Laouali, and N’goran David Vincent Kouakou. 2023. "Phytochemical Characterization and In Vitro Evaluation of the Anti-Sickle Cell Activity of Aqueous and Ethanolic Extracts of Two Medicinal Plants from Niger: Flueggea virosa (Roxb. ex Willd.) Royle and Kigelia africana (Lam.) Benth" Plants 12, no. 20: 3522. https://doi.org/10.3390/plants12203522

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop